NYSE:CRLLife Sciences
New Charles River Leaders May Shape Valuation, Debt And Governance Outlook
Charles River Laboratories International (NYSE:CRL) has appointed Glenn G. Coleman as Chief Financial Officer.
The company has also named Kerry Dailey as Chief Legal Officer, expanding its senior leadership bench.
These leadership changes are aimed at reinforcing financial oversight, legal governance, and corporate compliance.
Charles River Laboratories operates as a key partner for pharmaceutical and biotech companies, supporting drug discovery, preclinical research, and related services...